GB201421088D0 - New enzyme inhibitors - Google Patents
New enzyme inhibitorsInfo
- Publication number
- GB201421088D0 GB201421088D0 GBGB1421088.4A GB201421088A GB201421088D0 GB 201421088 D0 GB201421088 D0 GB 201421088D0 GB 201421088 A GB201421088 A GB 201421088A GB 201421088 D0 GB201421088 D0 GB 201421088D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- enzyme inhibitors
- new enzyme
- new
- inhibitors
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1421088.4A GB201421088D0 (en) | 2014-11-27 | 2014-11-27 | New enzyme inhibitors |
PCT/GB2015/053610 WO2016083816A1 (en) | 2014-11-27 | 2015-11-26 | N-((heteroarylmethyl)-heteroaryl-carboxamide derivatives as plasma kallikrein inhibitors |
SG11201809276QA SG11201809276QA (en) | 2014-11-27 | 2015-11-26 | N-((heteroarylmethyl)-heteroaryl-carboxamide derivatives as plasma kallikrein inhibitors |
ARP150103902A AR102852A1 (en) | 2014-11-27 | 2015-11-26 | HETEROCYCLIC INHIBITORS OF PLASMA CALICREINE |
TW104139777A TWI675832B (en) | 2014-11-27 | 2015-11-27 | New enzyme inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1421088.4A GB201421088D0 (en) | 2014-11-27 | 2014-11-27 | New enzyme inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201421088D0 true GB201421088D0 (en) | 2015-01-14 |
Family
ID=52349556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1421088.4A Ceased GB201421088D0 (en) | 2014-11-27 | 2014-11-27 | New enzyme inhibitors |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR102852A1 (en) |
GB (1) | GB201421088D0 (en) |
SG (1) | SG11201809276QA (en) |
TW (1) | TWI675832B (en) |
WO (1) | WO2016083816A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI636047B (en) | 2013-08-14 | 2018-09-21 | 英商卡爾維斯塔製藥有限公司 | Heterocyclic derivatives |
MX2016008688A (en) | 2013-12-30 | 2017-01-12 | Lifesci Pharmaceuticals Inc | Therapeutic inhibitory compounds. |
US9611252B2 (en) | 2013-12-30 | 2017-04-04 | Lifesci Pharmaceuticals, Inc. | Therapeutic inhibitory compounds |
GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
GB201421085D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | New enzyme inhibitors |
RS60600B1 (en) | 2016-05-31 | 2020-08-31 | Kalvista Pharmaceuticals Ltd | Pyrazole derivatives as plasma kallikrein inhibitors |
GB201609603D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide |
GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
WO2018011628A1 (en) * | 2016-07-11 | 2018-01-18 | Lifesci Pharmaceuticals, Inc. | Therapeutic inhibitory compounds |
US11168080B2 (en) | 2017-04-26 | 2021-11-09 | Mitobridge, Inc. | Dynamin-1-like protein inhibitors |
GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
GB201721515D0 (en) * | 2017-12-21 | 2018-02-07 | Kalvista Pharmaceuticals Ltd | Dosage forms comprising a plasma kallikrein inhibtor |
RU2020121151A (en) | 2017-11-29 | 2021-12-29 | Калвиста Фармасьютикалз Лимитед | DOSAGE FORMS CONTAINING PLASMA KALLIKREIN INHIBITOR |
KR20200143376A (en) | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | Substituted imidazopyridines and uses thereof as plasma kallikrein inhibitors |
HU231478B1 (en) | 2018-07-13 | 2024-02-28 | Richter Gedeon Nyrt. | Substituted (aza)indole derivatives |
WO2021028645A1 (en) | 2019-08-09 | 2021-02-18 | Kalvista Pharmaceuticals Limited | Plasma kallikrein inhibitors |
EP4017850A1 (en) | 2019-08-21 | 2022-06-29 | Kalvista Pharmaceuticals Limited | Enzyme inhibitors |
EP4017587A1 (en) | 2019-08-21 | 2022-06-29 | Kalvista Pharmaceuticals Limited | Enzyme inhibitors |
AU2019462140A1 (en) | 2019-08-21 | 2022-02-24 | Kalvista Pharmaceuticals Limited | Enzyme inhibitors |
WO2021032933A1 (en) | 2019-08-21 | 2021-02-25 | Kalvista Pharmaceuticals Limited | Enzyme inhibitors |
US11370803B2 (en) | 2019-09-18 | 2022-06-28 | Takeda Pharmaceutical Company Limited | Heteroaryl plasma kallikrein inhibitors |
JP2022548696A (en) * | 2019-09-18 | 2022-11-21 | 武田薬品工業株式会社 | Plasma kallikrein inhibitors and uses thereof |
WO2024059186A1 (en) * | 2022-09-15 | 2024-03-21 | Takeda Pharmaceutical Company Limited | N-((isoquinolin-6-yl)methyl)-1h-pyrazole-4-carboxamid derivatives as plasma kallikrein inhibitors for the treatment of hereditary angioedema |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
GB9019558D0 (en) | 1990-09-07 | 1990-10-24 | Szelke Michael | Enzyme inhibitors |
SE9301911D0 (en) | 1993-06-03 | 1993-06-03 | Ab Astra | NEW PEPTIDE DERIVATIVES |
US5589467A (en) | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
GB0205527D0 (en) | 2002-03-08 | 2002-04-24 | Ferring Bv | Inhibitors |
EP3168304A1 (en) | 2003-08-27 | 2017-05-17 | Ophthotech Corporation | Combination therapy for the treatment of ocular neovascular disorders |
US7429604B2 (en) | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
CA2658523C (en) | 2006-07-31 | 2012-06-12 | Activesite Pharmaceuticals, Inc. | Inhibitors of plasma kallikrein |
DE102006050672A1 (en) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations |
GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
JP2013121919A (en) | 2010-03-25 | 2013-06-20 | Astellas Pharma Inc | Plasma kallikrein inhibitor |
WO2012004678A2 (en) | 2010-07-07 | 2012-01-12 | The Medicines Company (Leipzig) Gmbh | Serine protease inhibitors |
EP2595986A2 (en) | 2010-07-14 | 2013-05-29 | Addex Pharma SA | Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
WO2013111108A1 (en) | 2012-01-27 | 2013-08-01 | Novartis Ag | 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
EP2807156A1 (en) | 2012-01-27 | 2014-12-03 | Novartis AG | Aminopyridine derivatives as plasma kallikrein inhibitors |
GB201300304D0 (en) | 2013-01-08 | 2013-02-20 | Kalvista Pharmaceuticals Ltd | Benzylamine derivatives |
RU2712621C2 (en) * | 2013-05-23 | 2020-01-30 | Калвиста Фармасьютикалз Лимитед | Nitrogen-containing heterocyclic derivatives useful as plasma kallikrein inhibitor |
TWI636047B (en) * | 2013-08-14 | 2018-09-21 | 英商卡爾維斯塔製藥有限公司 | Heterocyclic derivatives |
-
2014
- 2014-11-27 GB GBGB1421088.4A patent/GB201421088D0/en not_active Ceased
-
2015
- 2015-11-26 AR ARP150103902A patent/AR102852A1/en unknown
- 2015-11-26 WO PCT/GB2015/053610 patent/WO2016083816A1/en active Application Filing
- 2015-11-26 SG SG11201809276QA patent/SG11201809276QA/en unknown
- 2015-11-27 TW TW104139777A patent/TWI675832B/en active
Also Published As
Publication number | Publication date |
---|---|
AR102852A1 (en) | 2017-03-29 |
TW201629039A (en) | 2016-08-16 |
TWI675832B (en) | 2019-11-01 |
SG11201809276QA (en) | 2018-11-29 |
WO2016083816A1 (en) | 2016-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287113A (en) | Smyd inhibitors | |
IL277167B (en) | Cyclopropylamines as lsd1 inhibitors | |
IL277299B (en) | Cyclopropylamines as lsd1 inhibitors | |
IL257880B (en) | Beta-lactamase inhibitors | |
GB201421083D0 (en) | Enzyme inhibitors | |
IL246785A0 (en) | Benzimidazol-2-amines as midh1 inhibitors | |
GB201421088D0 (en) | New enzyme inhibitors | |
EP3116503A4 (en) | Hptp-beta inhibitors | |
HK1226398A1 (en) | Benzimidazol-2-amines as midh1 inhibitors | |
IL248895A0 (en) | Phosphatidylinositol -kinase inhibitors | |
GB201416446D0 (en) | New enzyme inhibitor compounds | |
GB201421085D0 (en) | New enzyme inhibitors | |
IL247025A0 (en) | Enzyme inhibitors | |
GB201401005D0 (en) | Inhibitor | |
EP3180003A4 (en) | Pkc-epsilon inhibitors | |
GB201609517D0 (en) | Enzyme inhibitors | |
GB201418154D0 (en) | Inhibitors | |
GB201415549D0 (en) | Enzyme inhibition | |
GB201415554D0 (en) | Enzyme inhibition | |
AU2014900535A0 (en) | Inhibitors | |
AU2014900536A0 (en) | Inhibitors | |
GB201404718D0 (en) | Modified enzymes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |